Titlebook: Handbuch Visuelle Kommunikationsforschung; Katharina Lobinger Living reference work 2020Latest edition

只看該作者 · 發(fā)表于 2025-3-30 11:49:39

Marion G. Müller,Thomas Knieperto current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based combination therapies has great promise to achieve high frequency and durable responses in the ma

只看該作者 · 發(fā)表于 2025-3-30 15:07:33

Mira Mayrhofer,Alice Binder,J?rg Matthesto current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based combination therapies has great promise to achieve high frequency and durable responses in the ma

只看該作者 · 發(fā)表于 2025-3-30 18:05:50

只看該作者 · 發(fā)表于 2025-3-30 23:30:40

Clemens Schwender,Thomas Petersen development of novel therapies.Explores all clinically impoDespite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment appro

只看該作者 · 發(fā)表于 2025-3-31 02:18:22

只看該作者 · 發(fā)表于 2025-3-31 07:42:37

Tanja Maier,Martina Thiele development of novel therapies.Explores all clinically impoDespite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment appro

只看該作者 · 發(fā)表于 2025-3-31 10:31:03

只看該作者 · 發(fā)表于 2025-3-31 16:44:41

Ulla Patricia Autenrieth development of novel therapies.Explores all clinically impoDespite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment appro

只看該作者 · 發(fā)表于 2025-3-31 21:07:25

Cornelia Brantner development of novel therapies.Explores all clinically impoDespite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment appro

只看該作者 · 發(fā)表于 2025-4-1 01:37:32

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 09:22
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved